We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ADTX market cap is 4.12M. The company's latest EPS is USD -9.0764 and P/E is -0.13.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 221k | 125k | 81k | 80k | 44k |
| Operating Income | -4.23M | -8.1M | -7.95M | -11.54M | -5.98M |
| Net Income | -5.68M | -9.91M | -11.12M | -14.73M | -7.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 105k | 934k | 645k |
| Operating Income | -5.87M | -8.87M | -27.44M | -24.94M | -26.06M |
| Net Income | -5.83M | -9.15M | -46.37M | -27.65M | -32.7M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.29M | 8.23M | 44.58M | 27.98M | 28.37M |
| Total Liabilities | 11.16M | 12.45M | 28.53M | 18.19M | 22.03M |
| Total Equity | -3.87M | -4.22M | 16.05M | 9.78M | 6.34M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 124k | 13.1M | 16.66M | 10.74M | 44.58M |
| Total Liabilities | 2.98M | 2.09M | 6.48M | 5.53M | 28.53M |
| Total Equity | -2.85M | 11.01M | 10.18M | 5.21M | 16.05M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.23M | -15.27M | -18.58M | -5.96M | -8.25M |
| Investing | -5k | -14k | -14k | N/A | -1M |
| Financing | 4.57M | 14.17M | 15.92M | 5.95M | 9.25M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -464k | -7.22M | -22.28M | -22.39M | -18.58M |
| Investing | N/A | -171k | -16.31M | -242k | -14k |
| Financing | 352k | 17.89M | 35.96M | 17.53M | 15.92M |
| Market Cap | 4.12M |
| Price to Earnings Ratio | -0.13 |
| Price to Sales Ratio | 6.42 |
| Price to Cash Ratio | 42.75 |
| Price to Book Ratio | 0.26 |
| Dividend Yield | - |
| Shares Outstanding | 3.6M |
| Average Volume (1 week) | 11.79M |
| Average Volume (1 Month) | 7.71M |
| 52 Week Change | -89.51% |
| 52 Week High | 13.70 |
| 52 Week Low | 0.0915 |
| Spread (Intraday) | 0.03 (2.56%) |
| Company Name | Aditxt Inc |
| Address |
2140 s dupont hwy camden, delaware 19934 |
| Website | https://www.aditxt.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
